September 10, 2026
Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Dietary Supplement Innovation Act”.